Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

111.10USD
14 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
$111.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
104
52-wk High
$122.43
52-wk Low
$88.95

LZAGF.PK

Chart for LZAGF.PK

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 1.39
Market Cap (Mil.): CHF5,657.16
Shares Outstanding (Mil.): 52.92
Dividend: 2.15
Yield (%): 2.01

Financials

  LZAGF.PK Industry Sector
P/E (TTM): 29.93 20.75 24.61
EPS (TTM): 3.57 -- --
ROI: 3.26 6.59 14.48
ROE: 8.81 8.48 16.67
Search Stocks

BRIEF-Lonza establishes manufacturing agreement with Celladon

* Lonza and Celladon corporation establish a strategic commercial manufacturing collaboration for Mydicar Further company coverage:

03 Nov 2014

UPDATE 2-Lonza shares drop after revenue forecast cut on weak water business

* Shares fall as much as 8.5 pct (Recasts with fall in shares, adds analyst comments)

31 Oct 2014

BUZZ-Lonza tumbles on revenue forecast downgrade

** Shares in Lonza fall 5 pct to 110.0 Swiss francs after the specialty chemicals and life science group lowers its full-year revenue forecast.

31 Oct 2014

BRIEF-Lonza falls 3.5 pct after lowers revenue forecast

ZURICH, Oct 31 - Lonza Group AG falls 3.5 percent after it lowers its full-year revenue forecast. Further company coverage: (Reporting by Caroline Copley)

31 Oct 2014

BRIEF-Lonza CEO says has no divestment plans at present

Oct 31 - Citigroup Inc : * Lonza CEO says company does not have any divestment projects ongoing right

31 Oct 2014

Lonza lowers revenue forecasts on weak water business

ZURICH, Oct 31 - Switzerland's Lonza revised down its forecast for full-year revenue growth on Friday as bad weather weighed on its water business.

31 Oct 2014

BRIEF-Lonza decides to keep its wood protection business

Oct 31 - Lonza Group AG : * Says has decided to retain its wood protection business

31 Oct 2014

Lonza courts biotech backers to shore up outsourcing contracts

ZURICH - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.

22 Aug 2014

Lonza courts biotech backers to shore up outsourcing contracts

ZURICH, Aug 22 - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.

22 Aug 2014

UPDATE 2-Lonza profit boosted by drug production outsourcing

* Shares up 5.8 pct (Recasts with share price, adds analyst)

24 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks